Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis.

British journal of cancer - 17 Jan 2005

Mascaux C, Iannino N, Martin B, Paesmans M, Berghmans T, Dusart M, Haller A, Lothaire P, Meert A-P, Noel S, Lafitte J-J, Sculier J-P

Abstract excerpt

The proto-oncogene RAS, coding for a 21 kDa protein (p21), is mutated in 20% of lung cancer. However, the literature remains controversial on its prognostic significance for survival in lung cancer. We performed a systematic review of the literature with meta-analysis to assess its possible prognostic value on survival. Published studies on lung cancer assessing prognostic value of RAS mutation or p21...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Genes, ras

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Mutation

Share to Prognosis

Share to Proto-Oncogene Mas

Share to Sensitivity and Specificity

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 15597105
DOI: 10.1038/sj.bjc.6602258
PMCID: PMC2361730

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis.PMID 15597105Read ↗

Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis.Semantic proximity Read ↗

K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: a combined analysis of 881 cases.Semantic proximity Read ↗

Ras oncogene mutations and survival in patients with lung cancer.Semantic proximity Read ↗

The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.Semantic proximity Read ↗

K-ras mutations in non-small-cell lung carcinoma: a review.Semantic proximity Read ↗

KRAS Mutation as a Biomarker for Survival in Patients with Non-Small Cell Lung Cancer, A Meta-Analysis of 12 Randomized Trials.Semantic proximity Read ↗

Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis.Semantic proximity Read ↗

Prognostic and predictive value of K-RAS mutations in non-small cell lung cancer.Semantic proximity Read ↗

[K-ras oncogene in bronchial cancer. Its current prognostic role and long-term therapeutic perspectives].Semantic proximity Read ↗

Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patientsSemantic proximity Read ↗

K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancerSemantic proximity Read ↗

The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.